Researcher
Stijn De Munter
- Disciplines:Diagnostics, Medicinal products, Laboratory medicine
Affiliations
- Department of Diagnostic Sciences (Department)
Member
From1 Oct 2018 → Today - Department of Clinical chemistry, microbiology and immunology (Department)
Member
From1 Sep 2015 → 30 Sep 2018
Projects
1 - 3 of 3
- Chimeric antigen receptor unconventional T cell therapy (CAR-uT) for the treatment of solid tumorsFrom1 Nov 2023 → TodayFunding: FWO junior postdoctoral fellowship
- Optimising CD70-specific T cell therapy for solitary and haematological malignanciesFrom1 Nov 2022 → 31 Oct 2023Funding: BOF - doctoral mandates
- Generation of chimeric antigen receptor expressing, T cell receptor negative CD4 helper and CD8 cytotoxic cells starting from cord blood hematopoietic precursor cells that are optimized for in vivo tumor eradication.From1 Oct 2015 → 30 Sep 2019Funding: FWO fellowships
Publications
1 - 10 of 15
- Single-cell profiling identifies a novel human polyclonal unconventional T cell lineage(2023)
Authors: Lore Billiet, Laurenz De Cock, Guillem Sanchez Sanchez, Rupert Mayer, Glenn Goetgeluk, Stijn De Munter, Melissa Pille, Joline Ingels, Hanne Jansen, Karin Weening, et al.
- The Wiskott–Aldrich syndrome protein is required for positive selection during T-cell lineage differentiation(2023)
Authors: John Avila, Guillem Sanchez Sanchez, Glenn Goetgeluk, Stijn De Munter, Hanne Jansen, Lore Billiet, Karin Weening, Haipeng Xue, Eva Pascal, Lucas Deseins, et al.
- Delivery of macromolecules in unstimulated T cells by photoporation with polydopamine nanoparticles(2023)
Authors: Dominika Berdecka, Aranit Harizaj, Ilia Goemaere, Deep Punj, Glenn Goetgeluk, Stijn De Munter, Herlinde De Keersmaecker, Veerle Boterberg, Winnok H. De Vos, Kevin Braeckmans
Pages: 680 - 693 - Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials(2022)
Authors: Rupert Mayer, Pam Devreker, Karin Weening, Nele Lootens, Saskia De Smet, Marieke Brusseel, Stijn De Munter, Lore Billiet, Glenn Goetgeluk, Hanne Jansen, et al.
Pages: 213 - 222 - Photothermal nanofibres enable safe engineering of therapeutic cells(2021)
Authors: Ranhua Xiong, Dawei Hua, Jelter Van Hoeck, Dominika Berdecka, Laurens Léger, Stijn De Munter, Juan Fraire, Laurens Raes, Aranit Harizaj, Félix Sauvage, et al.
Pages: 1281 - 1291 - In vitro OP9-DL1 co-culture and subsequent maturation in the presence of IL-21 generates tumor antigen-specific T cells with a favorable less-differentiated phenotype and enhanced functionality(2021)
Authors: Sarah Bonte, Stijn De Munter, Lore Billiet, Glenn Goetgeluk, Joline Ingels, Hanne Jansen, Melissa Pille, Laurenz De Cock, Karin Weening, Tom Taghon, et al.
- Intracellular delivery of mRNA in adherent and suspension cells by vapor nanobubble photoporation(2020)
Authors: Laurens Raes, Stephan Stremersch, Juan Fraire, Toon Brans, Glenn Goetgeluk, Stijn De Munter, Lien Van Hoecke, Rein Verbeke, Jelter Van Hoeck, Ranhua Xiong, et al.
- Human thymic CD10+ PD-1+ intraepithelial lymphocyte precursors acquire interleukin-15 responsiveness at the CD1a– CD95+ CD28– CCR7– developmental stage(2020)
Authors: Lore Billiet, Glenn Goetgeluk, Sarah Bonte, Stijn De Munter, Laurenz De Cock, Melissa Pille, Joline Ingels, Hanne Jansen, Karin Weening, Filip Van Nieuwerburgh, et al.
- T-cells with a single tumor antigen-specific T-cell receptor can be generated in vitro from clinically relevant stem cell sources(2020)
Authors: Sarah Bonte, Stijn De Munter, Glenn Goetgeluk, Joline Ingels, Melissa Pille, Lore Billiet, Tom Taghon, Georges Leclercq, Bart Vandekerckhove, Tessa Kerre
- TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment(2020)
Authors: Barbara Depreter, Karin Weening, Karl Vandepoele, Magnus Essand, Maria Themeli, Jacqueline Cloos, Diana Hanekamp, Ine Moors, INGE D'HONT, Barbara Denys, et al.
Pages: 1306 - 1316